December 12, 2023
Amanda Su
Share
https://www.journal-of-hepatology.eu/action/showPdf?pii=S0168-8278%2821%2902234-0
Can seladelpar serve as second-line treatment for PBC patients with inadequate UDCA therapy?
October 27, 2025
HepMadness
October 15, 2025
The Psychosocial Challenges of Liver Transplantation
October 14, 2025
